H-GYLQPRTFL-OH

Rif. 3D-PP49024

Informazioni sul prodotto

• Nome: H-GYLQPRTFL-OH

Descrizione

Peptide H-GYLQPRTFL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GYLQPRTFL-OH include the following: A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection TT Tzeng, KM Chai, KY Shen, CY Yu , SJ Yang - npj Vaccines, 2022 - nature.comhttps://www.nature.com/articles/s41541-022-00482-0 Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine R Wadapurkar , S Singh, A Singh - Vaccine, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X24001117 Process-and product-related impurities in the ChAdOx1 nCov-19 vaccine L Krutzke, R Rösler, E Allmendinger, T Engler, S Wiese - Elife, 2022 - elifesciences.orghttps://elifesciences.org/articles/78513 Short-and long-interval prime-boost vaccination with the candidate vaccines MVA-SARS-2-ST and MVA-SARS-2-S induces comparable humoral and cell-mediated G Kalodimou, S Jany, A Freudenstein, JH Schwarz - Viruses, 2023 - mdpi.comhttps://www.mdpi.com/1999-4915/15/5/1180 Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity CM Zu Natrup, A Tscherne, C Dahlke - The Journal of , 2022 - Am Soc Clin Investighttps://www.jci.org/articles/view/159895 Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination A Tscherne, JH Schwarz , C Rohde - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2026207118

• Marchio: Biosynth